JUSRX
Price
$28.30
Change
-$0.23 (-0.81%)
Updated
Jul 13 closing price
Net Assets
32.82B
VSTSX
Price
$354.42
Change
-$2.83 (-0.79%)
Updated
Jul 13 closing price
Net Assets
2.3T
Interact to see
Advertisement

JUSRX vs VSTSX

JUSRX vs VSTSX Comparison Chart in %
View a ticker or compare two or three
VS
JUSRX vs. VSTSX commentary
Jul 14, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JUSRX is a Buy and VSTSX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VSTSX has more cash in the bank: 2.3T vs. JUSRX (32.8B). VSTSX pays higher dividends than JUSRX: VSTSX (1.07) vs JUSRX (0.49). JUSRX was incepted earlier than VSTSX: JUSRX (20 years) vs VSTSX (10 years). JUSRX (0.56) is less costly to investors than VSTSX (0.01). JUSRX is a more actively managed with annual turnover of: 39.00 vs. VSTSX (3.00). JUSRX has a lower initial minimum investment than VSTSX: JUSRX (0) vs VSTSX (5000000000). VSTSX annual gain was more profitable for investors over the last year : 21.48 vs. JUSRX (8.17). VSTSX return over 5 years is better than : 66.56 vs. JUSRX (32.43).
JUSRXVSTSXJUSRX / VSTSX
Total Expense Ratio0.540.015,400%
Annual Report Gross Expense Ratio0.560.015,600%
Fund Existence20 years10 years-
Gain YTD5.99211.20553%
Front LoadN/AN/A-
Min. Initial Investment05000000000-
Min. Initial Investment IRAN/AN/A-
Net Assets32.8B2.3T1%
Annual Yield % from dividends0.491.0746%
Returns for 1 year8.1721.4838%
Returns for 3 years43.9267.0665%
Returns for 5 years32.4366.5649%
Returns for 10 years115.47239.5348%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PWCIX95.22N/A
N/A
Principal Capital Appreciation Inst
PRLAX24.44N/A
N/A
T. Rowe Price Latin America
PACLX37.66N/A
N/A
T. Rowe Price Capital Appreciation Adv
RLIEX20.52N/A
N/A
Lazard International Equity R6
MCYIX16.37-0.51
-3.02%
NYLI Candriam Emerging Markets Eq Cl I